Market Cap 903.78M
Revenue (ttm) 0.00
Net Income (ttm) -176.21M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,160,200
Avg Vol 949,140
Day's Range N/A - N/A
Shares Out 52.82M
Stochastic %K 84%
Beta 2.67
Analysts Sell
Price Target $14.60

Company Profile

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that has complete Phase 3 clinical study to treat high prevalence retinal vascular diseases; and in Phase 3 clinical study for the treatment of diabetic retinopathy, wet age-related macular degenerati...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 281 0850
Website: kodiak.com
Address:
1200 Page Mill Road, Palo Alto, United States
Cutlass
Cutlass Oct. 24 at 9:08 PM
$KOD . . . and a Good Week +32% ✅
0 · Reply
spinusn27
spinusn27 Oct. 24 at 8:42 PM
$KOD good day today. Gap filled the open and closed nicely. Have a great weekend 😀
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Oct. 24 at 1:18 PM
0 · Reply
Cutlass
Cutlass Oct. 24 at 12:05 PM
$KOD 👀
0 · Reply
erevnon
erevnon Oct. 24 at 11:08 AM
JP Morgan upgrades Kodiak Sciences $KOD from Neutral to Overweight and raises the price target from $15 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
JarvisFlow
JarvisFlow Oct. 24 at 10:30 AM
JP Morgan updates rating for Kodiak Sciences ( $KOD ) to Overweight, target set at 15 → 24.
0 · Reply
notreload_ai
notreload_ai Oct. 24 at 9:42 AM
JPMorgan raises $KOD rating to Overweight with $24 price target, citing reduced risk for KSI-101 drug treating eye inflammation and swelling. https://notreload.xyz/jpmorgan-upgrades-kodiak-sciences-ksi-101-potential/
0 · Reply
JarvisFlow
JarvisFlow Oct. 23 at 9:49 PM
LifeSci Capital has adjusted their stance on Kodiak Sciences ( $KOD ), setting the rating to Outperform with a target price of 40.
0 · Reply
Stekli27
Stekli27 Oct. 21 at 8:17 PM
$KOD Nostradamus 😋
0 · Reply
Cutlass
Cutlass Oct. 21 at 6:45 PM
$KOD Very - 400% and holding
0 · Reply
Latest News on KOD
Harbour BioMed Reports 2025 Interim Results

Aug 27, 2025, 10:40 AM EDT - 2 months ago

Harbour BioMed Reports 2025 Interim Results


Kodiak Sciences to Host Investor R&D Day on July 16, 2025

Jul 10, 2025, 8:00 AM EDT - 3 months ago

Kodiak Sciences to Host Investor R&D Day on July 16, 2025


Kodiak Sciences: Anti-VEGF Could Win Nicely On Retinal Disorders

Feb 23, 2025, 8:08 PM EST - 8 months ago

Kodiak Sciences: Anti-VEGF Could Win Nicely On Retinal Disorders


Kodiak Sciences to Present at Innovate Retina 2024

Oct 14, 2024, 5:35 PM EDT - 1 year ago

Kodiak Sciences to Present at Innovate Retina 2024


Kodiak Sciences Inc. (KOD) Q4 2023 Earnings Call Transcript

Mar 28, 2024, 8:57 PM EDT - 1 year ago

Kodiak Sciences Inc. (KOD) Q4 2023 Earnings Call Transcript


Kodiak Sciences scraps development of eye disorder drug

Jul 24, 2023, 6:38 AM EDT - 2 years ago

Kodiak Sciences scraps development of eye disorder drug


Kodiak Sciences to Present at Upcoming Investor Conferences

May 30, 2023, 4:15 PM EDT - 2 years ago

Kodiak Sciences to Present at Upcoming Investor Conferences


Cutlass
Cutlass Oct. 24 at 9:08 PM
$KOD . . . and a Good Week +32% ✅
0 · Reply
spinusn27
spinusn27 Oct. 24 at 8:42 PM
$KOD good day today. Gap filled the open and closed nicely. Have a great weekend 😀
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Oct. 24 at 1:18 PM
0 · Reply
Cutlass
Cutlass Oct. 24 at 12:05 PM
$KOD 👀
0 · Reply
erevnon
erevnon Oct. 24 at 11:08 AM
JP Morgan upgrades Kodiak Sciences $KOD from Neutral to Overweight and raises the price target from $15 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
JarvisFlow
JarvisFlow Oct. 24 at 10:30 AM
JP Morgan updates rating for Kodiak Sciences ( $KOD ) to Overweight, target set at 15 → 24.
0 · Reply
notreload_ai
notreload_ai Oct. 24 at 9:42 AM
JPMorgan raises $KOD rating to Overweight with $24 price target, citing reduced risk for KSI-101 drug treating eye inflammation and swelling. https://notreload.xyz/jpmorgan-upgrades-kodiak-sciences-ksi-101-potential/
0 · Reply
JarvisFlow
JarvisFlow Oct. 23 at 9:49 PM
LifeSci Capital has adjusted their stance on Kodiak Sciences ( $KOD ), setting the rating to Outperform with a target price of 40.
0 · Reply
Stekli27
Stekli27 Oct. 21 at 8:17 PM
$KOD Nostradamus 😋
0 · Reply
Cutlass
Cutlass Oct. 21 at 6:45 PM
$KOD Very - 400% and holding
0 · Reply
richard52
richard52 Oct. 21 at 3:03 PM
$ICU just looking at $KOD I was in it for a while but finally decided that this stock $ICU was where my heart belonged. The chart of KOD will hopefully be ours before too long.
1 · Reply
Cutlass
Cutlass Oct. 21 at 12:41 PM
$KOD Breaks 21 it could fly 👓
1 · Reply
PeaceThanks
PeaceThanks Oct. 20 at 11:50 PM
$KOD Next $CHRS
0 · Reply
spinusn27
spinusn27 Oct. 20 at 10:59 PM
$KOD follow the money. Baker Brothers and who ever else both the last couple of weeks.
0 · Reply
Cutlass
Cutlass Oct. 20 at 8:05 PM
$KOD +25% today, got gobbled up again 🎁
0 · Reply
geothug
geothug Oct. 20 at 6:42 PM
$KOD can someone please explain the bullush fundamentals here? After July 2023 i was pretty sure KOD was dead money. Not sure what I'm missing.
3 · Reply
spinusn27
spinusn27 Oct. 20 at 3:51 PM
$KOD oh
0 · Reply
buylowandwait
buylowandwait Oct. 20 at 3:44 PM
$KOD Double digits prediction was too conservative. My new prediction: KOD's ophthalmology asset will propel it to new historical high >150 ! This company hasn't had cash raise for long time, and after cash raise later this year, it will reach record high above 100 on P3 results.
1 · Reply
Cutlass
Cutlass Oct. 20 at 3:30 PM
$KOD My oh my - 👓🧨🎉
0 · Reply
_www_larval_com_
_www_larval_com_ Oct. 20 at 1:39 PM
$ELBM 16%[10%] $RAPT -11%[16%] $VSTM -10%[-15%] $HOND -9%[-6%] $KOD 9%[26%] most notable movement within the first minutes of trading.
0 · Reply
Stekli27
Stekli27 Oct. 20 at 12:30 PM
0 · Reply
Stekli27
Stekli27 Oct. 17 at 8:57 AM
0 · Reply